GLG Partners’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-22,998
Closed -$687K 481
2015
Q4
$687K Sell
22,998
-22,926
-50% -$773K 0.02% 349
2015
Q3
$1.45M Sell
45,924
-14,238
-24% -$695K 0.04% 315
2015
Q2
$2.91M Buy
60,162
+1,720
+3% +$72.5K 0.08% 257
2015
Q1
$2.53M Sell
58,442
-55,912
-49% -$2.01M 0.08% 224
2014
Q4
$3.01M Sell
114,354
-185,668
-62% -$4.07M 0.09% 210
2014
Q3
$5.33M Buy
300,022
+130,631
+77% +$2.67M 0.12% 198
2014
Q2
$4.07M Buy
169,391
+57,975
+52% +$1.18M 0.1% 203
2014
Q1
$2.8M Buy
+111,416
New +$3.08M 0.05% 233

Other funds holding PGEN

GLG Partners's PGEN Position: Q1 2016 in Review

GLG Partners sold out of Precigen (PGEN) in Q1 2016, closing a stake of 22,998 shares — an estimated $687K sold.

GLG Partners first reported a position in PGEN in Q1 2014 and held it in 8 quarters. The position peaked at $5.33M in Q3 2014. 191 funds tracked by Wall St. Rank hold PGEN as of Q1 2016.

  • GLG Partners reported no remaining Precigen position as of Q1 2016 after selling out during the quarter.
  • GLG Partners sold 22,998 Precigen shares in Q1 2016, an estimated $687K.
  • GLG Partners first reported a position in Precigen in Q1 2014 and held it in 8 quarters.
  • GLG Partners's Precigen position peaked at $5.33M in Q3 2014.
  • 191 funds tracked by Wall St. Rank held Precigen as of Q1 2016.

Based on GLG Partners's 13F filing for Q1 2016, filed 16 May 2016.